/Pharma tech
Invite

Pending to review

Not sure yet

Interested

Not interested

Get more companies

Download list

Company
Relevance
Description
Subspaces
HQ Location
Founded
Employees
Total Funding Raised
Funding Status
Received on
Picks for your space
Daten and Wissen is a customized Artificial Intelligence solutions provider. Working on some of the state-of-the-art technologies to convert it into a successful business run. The company is working with leading industries to support them on their digital transformation journey to optimize business processes and make insights based decision-making. We were established to enter the world of Artificial Intelligence, innovate, and help clients leverage the power of AI to increase their business. We are a DPIIT-recognized startup and also an NVIDIA Inception startup partner. Our Expertise: Computer Vision, Natural Language Processing, Time Series Predictions, Deep Learning, ChatBots, etc. Our Vision: To understand the market needs, create an Artificial Intelligence system for the needs, innovate, upgrade and grow together. Our Mission: To work on the path of creating a long-term solution using Artificial Intelligence to make the life of people pertaining to any domain easier, simpler, and more digital.
  • General Match
Thane (India)201911 - 50NA
2 days ago
Clarivio Advisors is a boutique healthcare consultancy helping organizations unlock the power of digital to transform care delivery, elevate patient experience, and drive meaningful impact. We partner with leaders across healthcare—biopharma, providers, and digital health companies—to shape strategy, design human-centered solutions, and accelerate innovation where it matters most.
  • General Match
Cambridge (United States)20251 - 10NA
2 days ago
We are a consultancy service located in Melbourne Australia servicing Australia and the APAC region. Our services focus on Medical Devices, ATMP's and the adoption and deployment of digitalisation and Industry 4.0 initiatives within GMP regulated industries. We are driven by our Mission: Working with Regulators, we are not afraid to be the first. We are passionate advocates for progress, driven by the belief that innovation and collaboration hold the key to the delivery of efficiency, compliance, and competitiveness. Contact us so we can help determine your new path.
  • General Match
Australia20231 - 10NA
2 days ago
Lebroy specializes in providing strategic solutions that drive growth, enhance efficiency, and unlock new opportunities. We partner with companies across industries to optimize operations, navigate challenges, and achieve their long-term goals. With a focus on innovation, data-driven insights, and tailored strategies, we help businesses transform and thrive in today’s competitive market.
  • General Match
201151 - 200NA
2 days ago
The company primarily operates in Financial Services. Fåhraeus Startup and Growth Fund was founded in 2021 and is headquartered in Lund, Sweden.
  • General Match
Lund (Sweden)20211 - 10NA
2 days ago
At Neotypica, we are pioneering the use of artificial intelligence to address social determinants of health (SDoH) in clinical trials. Our mission is to ensure that everyone, including underrepresented groups and emerging healthcare markets, has access to breakthrough research and life-saving innovative medicines. We provide culturally sensitive and comprehensive support to universities, foundations, and life science companies to achieve this goal.
  • General Match
Miami (United States)20241 - 10$1.00MSeed, $1.00M, August 20, 2024
2 days ago
zPREDICTA’s bio-simulation technology combines biology with automation and computation to automate drug development. zPREDICTA's bio-simulation platform enables pharma to rapidly identify drug candidates that will be effective in patients. r-Organ is a set of next generation 3D culture models that provide 1-to-1 reconstruction of human tissue microenvironment in an organ- and disease-specific manner allowing accurate prediction of drug response. Utilizing r-Organ technology, zPREDICTA is mapping cellular behavior in response to anticancer drugs.
  • General Match
San Jose (United States)20141 - 10$100.00KAcquired, December 2021
2 days ago
Securing Supply Chains Using Proof of Location Technology Unlock unprecedented levels of transparency, efficiency, and security in your supply chain. Our proof of location protocol ensures every asset is smart, traceable, and protected against modern challenges. ServBlock helps manufacturing companies unlock value through trusted data sharing. Gain real time visibility and insights through the value chain.
  • General Match
Dublin (Ireland)20211 - 10Pre-Seed, December 20, 2022
2 days ago
DataAppraisal employs groundbreaking appraisal technology that enables healthcare enterprises to maximize the value of their data assets. Our innovative approach unlocks previously untapped opportunities for growth, innovation, and optimization. We provide precise and comprehensive data appraisals by leveraging cutting-edge artificial intelligence, empowering organizations to harness the value of their healthcare data. Connect and learn more about our mission to transform the healthcare landscape by creating revenue opportunities, supporting research collaboration, and improving health outcomes.
  • General Match
Overland Park (United States)20211 - 10$1.00MPre-Seed, $1.00M, April 20, 2023
2 days ago
We are a fit-for-purpose drug development organization dedicated to your unique project's needs. Drug Engine Pharma (DEP) will customize a CMC strategy, handpick service partners to create the ideal outsourcing solution for your project, and then manage the movement of your molecule towards your milestones.
  • General Match
Edwardsville (United States)20211 - 10NA
2 days ago
At Homox, we're pioneering the future of personalized healthcare. Our innovative approach leverages cutting-edge technologies like Artificial Intelligence, IoT, and Genetic Analysis to create dynamic Personal Digital Twins for individuals. These twins adapt and evolve with real-time health data, offering insights, predictions, and personalized interventions. Join us on LinkedIn to stay informed about the latest advancements in personalized medicine, healthcare technology, and our mission to empower individuals to take control of their health like never before. Welcome to the healthcare revolution with Homox.
  • General Match
Tehran (Iran)20231 - 10NA
2 days ago
SOMA Life Science Solutions (SOMA) is a global leader in advancing regenerative medicine therapies, committed to transforming cutting-edge research into impactful clinical solutions. Our mission is to bridge the gap between innovation and patient care, offering tailored strategies with the highest standards for quality, safety, and regulatory compliance. At SOMA, we specialize in providing comprehensive support throughout the drug development lifecycle. With a focus on regulatory-compliant solutions, we ensure a seamless journey from concept to commercialization, accelerating time-to-market without compromising on quality. Whether you're in the early stages of discovery or preparing for market approval, we provide expert guidance and solutions designed to optimize each phase of the process. Our services span all critical areas of drug development, including manufacturing, regulatory affairs, clinical trials, risk management, quality control, data analysis, market research, and FDA submissions. At the core of our approach is AI-driven innovation—we harness the power of artificial intelligence to enhance efficiency, precision, and outcomes at every stage, from early research through clinical trials and regulatory approval. By integrating AI into the development pipeline, we streamline decision-making, improve results, and ensure compliance with the highest regulatory standards. We excel at breaking down complex challenges into manageable steps, creating customized roadmaps that guide your product to market while ensuring timely, successful commercialization. With deep industry expertise, SOMA turns visionary ideas into life-changing therapies. We provide end-to-end support, from product development through regulatory approval to market launch, ensuring your product reaches its full potential. Partner with SOMA to navigate drug development complexities. Our AI-powered solutions accelerate progress and deliver therapies making a lasting impact on patients globally.
  • General Match
Lewisville (United States)20171 - 10NA
2 days ago
Amar BioSystems is a start-up specializing in the development of microfluidics and microreactor based technologies, solutions, and services for the biopharmaceutical and life science industry. At Amar BioSystems, we are committed to accelerating drug development processes, improving diagnostics, and driving innovations in biochemical analysis to support the next wave of nanomedicines for infectious diseases, cancer, and rare diseases. Our focus is on advancing nanomedicines, including mRNA vaccines and therapeutics, using innovative microfluidic systems. We are committed to nurturing partnerships with research institutions and industry. Together, we strive to deliver scalable, cost-effective solutions for developing formulations, processes, and analytics, from bench to bedside.
  • General Match
Mumbai (India)20241 - 10NA
2 days ago
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
  • General Match
India19901001 - 5000NA
2 days ago
Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience drug development to provide a precision medicine approach in clinical areas of high unmet need. Contact us to learn more about our company and solutions.
  • General Match
Cambridge (United Kingdom)20191 - 10$7.86MVenture - Series Unknown, February 9, 2026
2 days ago
Nowpx.com is a digital platform that allows populace access healthcare, individuals and drugs resellers can order for drugs of choice online and it is delivered to their doorstep, also they can order for diagnostics services.
  • General Match
Lagos (Nigeria)20211 - 10NA
2 days ago
SNS Research is a global market intelligence and consulting firm with a particular focus on the pharmaceutical industry. Developed by leading industry analysts, our industry research reports provide unique insights on established and emerging markets. Whether your focus is strategic planning, development, or marketing our reports allow you to make better decisions with self-assurance. Our services portfolio includes: Market Intelligence and Research Reports Market Intelligence Databases Market Research Subscription Services
  • General Match
Monroeville (United States)201911 - 50NA
2 days ago
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies.
  • General Match
Eagan (United States)200211 - 50$437.83MIPO, June 13, 2019
2 days ago
Founded in 2018, Chemical.AI leads the innovation in chemical synthesis through AI and automation. We work with over 100 companies and research institutes to enhance chemical synthesis strategies, processes, and productivity by integrating proprietary retrosynthesis algorithms, comprehensive chemical data, and state-of-the-art robotic lab automation. Our goal is to provide advanced cheminformatics and automated solutions across diverse sectors such as pharmaceuticals, materials, biomedicine, and chemical engineering.
  • General Match
Wuchang (China)201711 - 50$12.41MSeries B, $12.41M, November 8, 2022
2 days ago
We are providing IT solutions and consulting services for drug development
  • General Match
Japan20231 - 10NA
2 days ago
CCR stands for Creative Clinical Research - out-of-the-box thinking. The story of CCR started in 2010, providing medical scientific consulting in the area of clinical research to pharmaceutical companies. Now we offer a range of services in healthcare consulting domain such as: Medical Scientific Consulting, Data Mining / Data Management, Statistics, Resourcing, Webinars / Publication Writing, AMNOG Experience (Table-Wizard & Batch-ITC for AMNOG Dossiers), Mobile APP Studies and Medical Review Software. We are based in Berlin with a very dynamic and international team of highly experienced physicians, statisticians, data scientists and business manager. Our aim is to provide the most premium Healthcare Consulting and Data Management Services in Pharmaceutical & Life-Sciences industry. Our unique offering brings you the expertise and comprehensive services combined with agility, focus and cost-effectiveness. Our capabilities range from pre-clinical through Phase I to Phase IV trials and till drug marketing stage. We have been trusted by some of the most advanced drug developers to manage studies across extensive therapeutic areas. Follow our LinkedIn company page for company news, updates and relevant articles regarding our industry.
  • General Match
Berlin (Germany)201011 - 50NA
2 days ago
At Novo Nordisk Pharmatech, we are committed to developing life science solutions that enable medicines for our customers sustainably. We are proud that our innovative research and products help millions of people around the world live better lives. We are committed to making a difference with products that benefit people suffering from serious chronic diseases. We provide products to aid pharmaceutical manufacturing in four product areas: Recombinant Insu-lin, Enzymes, Benzalkonium Chloride, and Resins. We will continue strengthening our partnerships with those customers needing animal-free and reliable ingredients supplied securely and consistent-ly. Quality is our top priority, and we always ensure high batch-to-batch consistency across our prod-ucts according to regulations, with cGMP being a key capability. We have attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy. TrypsiNNex® TrypsiNNex® is an animal-free, recombinant porcine trypsin that delivers exceptional performance and consistency for highly regulated biopharma manufacturing processes. Launched in 2024. Recombinant Insulin Recombinant Insulin is used to produce monoclonal antibodies, virus vaccines, gene therapy drugs, and other innovative biologic products approved for use by regulatory bodies worldwide, including FDA and EMA. Benzalkonium Chloride (BKC) BKC is produced according to the highest cGMP standards and backed by complete regulatory doc-umentation. Our Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms through a wide pH range and are soluble in both oily and aqueous phases. We were established in 1949, acquired by Novo Nordisk in 1986 and have been part of the pharma-ceutical group since then.
  • General Match
Køge (Denmark)194951 - 200NA
2 days ago
Pharmaceutical Industry
  • General Match
Pakistan200951 - 200NA
2 days ago
Working with Companies in the Boston & New England region in these core competencies: * REPRESENTATION for CRO’s & CDMO’s, sales & business management support & training for CRO & CDMO sales teams, including private coaching. * OUTSOURCING support activities when collaborating with CRO’s & CDMO’s on scientific projects that are a genuine fit for all stakeholders, including expert analysis, evaluation and selection of CRO & CDMO partners to optimize outsourcing solutions. * Development, hosting, implementation, training & support of Customer Relationship Management (CRM) systems specifically for the CRO & CDMO sector. * BUSINESS DEVELOPMENT for the high-level facilitation of introductions and presentation of pipeline assets with licensing partners in EU & USA. * TECHNICAL services for research, development & Pharmaceutical Quality/CMC to help advance drug development pipelines, including, where necessary, the identification & support of Subject Matter Experts (SMEx) in this space.
  • General Match
Boston (United States)20101 - 10NA
2 days ago
We manufacture Tablet, Capsules (Beta & Non beta), Liquid & Dry Syrup, Ointment & lotion & Nutraceuticals (Export facility available)
  • General Match
Roorkee (India)201311 - 50NA
2 days ago